Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Pulse Biosciences, Inc. | plse-20201231xex32_1.htm |
| EX-31.2 - EX-31.2 - Pulse Biosciences, Inc. | plse-20201231xex31_2.htm |
| EX-31.1 - EX-31.1 - Pulse Biosciences, Inc. | plse-20201231xex31_1.htm |
| EX-21.1 - EX-21.1 - Pulse Biosciences, Inc. | plse-20201231xex21_1.htm |
| EX-10.10 - EX-10.10 - Pulse Biosciences, Inc. | plse-20201231xex10_10.htm |
| 10-K - 10-K - Pulse Biosciences, Inc. | plse-20201231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement Nos. 333-246346, 333-237577, 333-227974, 333-224800, 333-219104 and 333-219096 on Form S-3 and Registration Statement Nos. 333-237225, 333-229320, 333-222582, 333-221788, 333-218164, and 333-216897 on Form S-8 of our report dated March 12, 2021, relating to the financial statements of Pulse Biosciences, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ DELOITTE & TOUCHE LLP
San Jose, California
March 12, 2021